Let me read it out…!!!
We need something effective …!!!
Cool. Not yet recruiting, but will be in the UK.
From elsewhere on the Internet
"Takeda is developing an oral suspension of TAK 041, a G-protein coupled receptor 139 (GPR139) agonist, for the treatment of negative symptoms and/or cognitive impairment associated with schizophrenia. "
Hope it treats both negative and cognitive symptoms…which phase is tak 041 is at…??
Tak 041 is at which phase @twinklestars …??
Once this trial starts, it will be in phase 2.
Thanks sis…love u …!!! Take care…!!! Arent u going for morning walk…
It’s been over 100 degrees for 3 days, so no. That has set me back a bit. Hope it cools off, just glad I have air conditioning.
Have u ever considered entering a CBD clinical trial? There is a trial going on in Germany, I am thinking of taking part in it. 200mgx2/day. And one at Yale 800mg/day for 4 weeks.
I don’t think there’s anything near me, but glad to see they are still investigating this as an option.
Would tak-041 even work since we still have avolition to worry about ? Or would it treat avolition as well ? Never heard of motivational anhedonia